New drug shows promise in slowing kidney disease progression
NCT ID NCT07150338
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 27 times
Summary
This study tested a new drug that targets energy production in cells to see if it could slow the loss of kidney function in 45 adults with moderate to severe chronic kidney disease. Participants had declining kidney function and protein in their urine. The main goal was to measure how fast kidney function declined over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGE 3-4) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Premier Kidney clinic
Pasadena, Texas, 77504, United States
Conditions
Explore the condition pages connected to this study.